Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA01 - Molecular Subtypes and Prognostic Factors for SCLC and Neuroendocrine Tumors
- 10:45 - 11:45
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Fabio Pagni, Ferdinandos Skoulidis
-
+
Session Moderator
10:45 - 10:46 | Presenter: Fabio Pagni
- Abstract
Loading... -
+
Session Moderator
10:45 - 10:46 | Presenter: Ferdinandos Skoulidis
- Abstract
Loading... -
+
MA01.01 - Session Introduction
10:45 - 10:46 | Presenter: Fabio Pagni
- Abstract
Loading... -
+
MA01.02 - Session Introduction
10:46 - 10:47 | Presenter: Ferdinandos Skoulidis
- Abstract
Loading... -
+
MA01.03 - Exploiting DNA Methylation for Classification of SCLC Subtypes from Liquid Biopsies Using a Robust Machine Learning Approach
10:47 - 10:52 | Presenter: Simon Heeke
- Abstract
Loading... -
+
MA01.04 - Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance
10:52 - 10:57 | Presenter: Zsolt Megyesfalvi
- Abstract
Loading... -
+
MA01.05 - Immuno-microenvironment (TIME) Heterogeneity of Small Cell Lung Cancer (SCLC) Stratified by Molecular Subtypes
10:57 - 11:02 | Presenter: Jiyan DONG
- Abstract
Loading... -
+
MA01.06 - Discussant
11:02 - 11:12 | Presenter: Kenneth John O'Byrne
- Abstract
Loading... -
+
MA01.07 - From Molecular to Histological Characterization of Lung Carcinoids via Computer Vision and Spatial Genomics
11:12 - 11:17 | Presenter: émilie Mathian
- Abstract
Loading... -
+
MA01.08 - Impact of [18F]FDG PET/CT-derived Metabolic Parameters on Outcomes in Extensive-stage SCLC
11:17 - 11:22 | Presenter: Giuseppe Lamberti
- Abstract
Loading... -
+
MA01.09 - Characterising Aggressive Pulmonary Carcinoids Through Integrative Omics Analysis Within the lungNENomics Project
11:22 - 11:27 | Presenter: Alexandra Sexton-Oates
- Abstract
Loading... -
+
MA01.10 - Discussant
11:27 - 11:37 | Presenter: Michael Boyer
- Abstract
Loading... -
+
MA01.11 - Live Q&A
11:37 - 11:45
- Abstract
Loading...
-
+
OA03 - Molecular Targeted Treatments
- 14:30 - 15:40
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Andrew Ciupek, David R. Gandara
-
+
OA03.06 - CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC
15:02 - 15:12 | Presenter: Bob T. Li
- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-163 - Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
Presenter: Xiuning Le- Abstract
Loading...